Clinical Study of Approved and Investigational Contact Lenses
Public ClinicalTrials.gov record NCT02708524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.
Study identification
- NCT ID
- NCT02708524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 554 participants
Conditions and interventions
Conditions
Interventions
- Senofilcon C Contact Lens Device
- Comfilcon A Contact Lens Device
- Lotrafilcon B Contact Lens Device
- Samfilcon A Contact Lens Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2016 (Type not available)
- Primary completion
- Mar 2016 (Actual)
- Completion
- Mar 2016 (Actual)
- Last update posted
- Nov 9, 2016
2016
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Fruit Cove | Florida | — | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Longwood | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Bloomington | Illinois | — | — |
| Not listed | East Lansing | Michigan | — | — |
| Not listed | Medina | Minnesota | — | — |
| Not listed | Closter | New Jersey | — | — |
| Not listed | Vestal | New York | — | — |
| Not listed | Granville | Ohio | — | — |
| Not listed | Jacksonville | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Roanoke | Virginia | — | — |
| Not listed | West Allis | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02708524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2016 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02708524 live on ClinicalTrials.gov.